| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 03/24/2005 | US20050065346 anticoagulants; thrombosis; factor x inhibitor |
| 03/24/2005 | US20050065161 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
| 03/24/2005 | US20050065097 Liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 03/24/2005 | US20050065096 Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| 03/24/2005 | US20050065033 Method to inhibit ethylene responses in plants |
| 03/23/2005 | EP1516877A1 Amine derivatives as protease inhibitors |
| 03/23/2005 | EP1516021A1 Printing process using specified azo compounds |
| 03/23/2005 | EP1515941A1 2-naphthamide derivatives |
| 03/23/2005 | CN1599724A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 03/23/2005 | CN1597673A Paro methylsulfonyl phongl acrylic acid derivative and its preparation method and antiinflammation action |
| 03/23/2005 | CN1597672A Substituierte benzoylcyclohexandione |
| 03/22/2005 | US6870057 Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds |
| 03/22/2005 | US6869974 Pharmaceutical compounds |
| 03/22/2005 | US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 03/22/2005 | CA2257772C Bicyclic¬3.1.0|hexanes and related compounds |
| 03/17/2005 | WO2005023765A1 Method for catalyzing amidation reactions by the presence of co2 |
| 03/17/2005 | WO2005023422A2 Production and use of ionic liquids containing thiocyanato anions |
| 03/17/2005 | WO2005023261A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | WO2005023260A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | WO2005023235A1 Benzyl alcohol derivatives or salts thereof |
| 03/17/2005 | WO2005023198A2 Modafinil compositions |
| 03/17/2005 | WO2004106288A3 Ionic liquids containing guanidinium cations |
| 03/17/2005 | WO2004087061A3 Tubulin binding agents and corresponding prodrug constructs |
| 03/17/2005 | US20050059824 Using carbon dioxide; salt formation, hydrolysis |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | US20050059721 Nonsedating alpha-2 agonists |
| 03/17/2005 | US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor |
| 03/17/2005 | US20050059710 Diphenylamino ketone derivatives as MEK inhibitors |
| 03/17/2005 | US20050059668 Substituted acylpiperazine derivatives |
| 03/17/2005 | US20050059659 Carotenoid analogs or derivatives for controlling C-reactive protein levels |
| 03/17/2005 | US20050059635 Astaxanthin, beta-carotene, zeanthin, canthaxanthin |
| 03/17/2005 | US20050058635 Anticancer agents; therapy for infections; administering glutaminyl cyclase inhibitor; Alzheimer's disease; Down syndrome; controlling fertility; schizophrenia; skin disorders |
| 03/17/2005 | CA2538135A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | CA2537292A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/16/2005 | EP1514870A1 Prodrug and process for producing the same |
| 03/16/2005 | EP1514867A2 Substituted phenyl derivatives, their preparation and use |
| 03/16/2005 | EP1513829A2 Nicotinoyl derivatives as herbicidal compounds |
| 03/16/2005 | EP1513818A2 Heterocyclic inhibitors of kinases |
| 03/16/2005 | EP1513802A1 Alpha-sulfonylamino-acetonitriles |
| 03/16/2005 | EP1513527A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers |
| 03/16/2005 | EP1513523A1 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases |
| 03/16/2005 | EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 03/16/2005 | CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 03/16/2005 | CN1596248A Phenoxy amine compounds and compositions for delivering active agents |
| 03/16/2005 | CN1596240A Chalcone derivatives and their use to treat diseases |
| 03/16/2005 | CN1193019C Method and reagents for N-alkylating ureides |
| 03/15/2005 | US6867333 Epothilone synthesis building blocks iii and iv: asymmetrically substituted acyloins and acyloin derivatives, methods for their production and methods for the production of epothilones b, d and epothilone derivatives |
| 03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
| 03/15/2005 | US6867208 Vitronectin receptor antagonists, their preparation and their use |
| 03/10/2005 | WO2005021490A2 N-SULFONYL-α-AMINO-ACID DERIVATIVES |
| 03/10/2005 | WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | WO2004071447B1 Substituted azole derivatives as therapeutic agents |
| 03/10/2005 | WO2004041802A8 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 03/10/2005 | US20050054819 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis |
| 03/10/2005 | US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases |
| 03/10/2005 | US20050054685 Pharmaceutical composition |
| 03/10/2005 | US20050054679 For therapy of psychiatric and neurological disorders |
| 03/10/2005 | US20050054674 Activator of peroxisome proliferator-activated receptor |
| 03/10/2005 | US20050054639 Viricide against human t-cell leukemia/lymphoma virus infections |
| 03/10/2005 | US20050054637 Prophylaxis, therapy cardiovascular disorders |
| 03/10/2005 | US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | US20050054582 Para-amino benzoic acids as integrin antagonists |
| 03/10/2005 | US20050054559 Compounds for sustained release of orally delivered drugs |
| 03/10/2005 | US20050054534 Substituted benzoylcyclohexane diones for use as herbicides |
| 03/09/2005 | EP1512684A1 use of derivative of para-phenylenediamine substituted by a homopiperidine ring, for the dyeing of keratinous fibres |
| 03/09/2005 | EP1512460A1 Preparation and use of ionic liquids having thiocyanat as anion |
| 03/09/2005 | EP1511735A1 Imidazole compounds and their use as ligands of the alpha-" adrenoreceptors |
| 03/09/2005 | EP1511734A2 Compounds, compositions, and methods |
| 03/09/2005 | EP1511490A2 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 03/09/2005 | EP1511472A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 03/09/2005 | CN1592743A Inhibitors of glycogen synthase kinase 3 |
| 03/09/2005 | CN1592616A GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 03/09/2005 | CN1590375A TNF-alpha prodn. inhibitors |
| 03/09/2005 | CN1590374A TNF-alpha prodn. inhibitors |
| 03/09/2005 | CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 03/09/2005 | CN1192011C Calcium receptor-active arylalkyl amines |
| 03/08/2005 | US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents |
| 03/08/2005 | US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases |
| 03/08/2005 | US6864270 Iron binding agents |
| 03/08/2005 | US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy |
| 03/08/2005 | US6863838 Low melting point |
| 03/03/2005 | WO2005019240A2 Melanin concentrating hormone receptor antagonists |
| 03/03/2005 | WO2005019212A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 03/03/2005 | WO2005019185A1 Ionic liquids based on imidazolium salts incorporating a nitrile functionality |
| 03/03/2005 | WO2005019184A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 03/03/2005 | WO2005019183A1 Method for the production of purified 1,3-substituted imidazolium salts |
| 03/03/2005 | WO2005000309A3 Chemical compounds |
| 03/03/2005 | WO2004063166A8 Heterocyclic ppar modulators |
| 03/03/2005 | US20050049420 Process for producing N-halogenated organic compounds |
| 03/03/2005 | US20050049418 such as 3-benzyl-1-methoxy-4,5-dimethylimidazolium iodide; by-product inhibition; for recycling polyesters and polyamides |
| 03/03/2005 | US20050049303 Adamantane derivatives |
| 03/03/2005 | US20050049288 5-MEMBERED HETEROCYCLE-BASED p38 KINASE INHIBITORS |
| 03/03/2005 | US20050049248 Method of use of the compound that includes a conjugated polyene with between 7 to 14 double bonds, and cyclohexene rings with ether, phosphate, sulfate, dextran or other group which imparts water solubility; cancer, rheumatoid arthritis, stroke, cardiovascular inflammation |
| 03/03/2005 | US20050048522 Novel guanosine triphosphate (GTP) binding protein-coupled receptor proteins |
| 03/03/2005 | CA2534864A1 Ionic liquids based on imidazolium salts incorporating a nitrile functionality |
| 03/02/2005 | EP1509537A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 03/02/2005 | EP1509525A1 Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof |
| 03/02/2005 | EP1509502A1 Method of forming a carbon-carbon or carbon-heteroatom linkage |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1042279B1 Substituted beta-alanines |